SCGN and small cell lung carcinoma: Previous studies suggested that a hypoxia-HIF1A-AS2-autophagy interaction may play a role in drug sensitivity in SCLC, while a high expression of secreted phosphoprotein 1 (SPP1) inhibited autophagy and apoptosis, promoting the development of SCLC (57, 58).